ArticleFrontiers in pharmacology2022

Rifaximin Ameliorates Non-alcoholic Steatohepatitis in Mice Through Regulating gut Microbiome-Related Bile Acids.

Jie Jian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.